Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Jamsen, Kris M ^a   Duffull, Stephen B ^b   Tarning, Joel ^c,d   Lindegardh, Niklas ^c,d   White, Nicholas ^c,d   Simpson, Julie A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; MALARIA FALCIPARUM; POPULATION RESEARCH; SAMPLING; STRUCTURED QUESTIONNAIRE; ADOLESCENT; ADULT; CHILD; COMPUTER SIMULATION; INFANT; ORAL DRUG ADMINISTRATION; PREGNANCY; PRESCHOOL CHILD; QUESTIONNAIRE; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MODELS, STATISTICAL; PREGNANCY; QUESTIONNAIRES; YOUNG ADULT;

EID: 79959687225     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-181     Document Type: Article

References (31)

1. Guidelines for the treatment of malaria, Second Edition. World Health Organization, Geneva, Switzerland ISBN 978 92 4 154792 5 2010
2. Antimalarial dosing regimens and drug resistance. Barnes KI Watkins WM White NJ,, Trends Parasitol 2008 24 127 134 18262470
3. Towards optimal design of antimalarial pharmacokinetic studies. Simpson JA Jamsen KM Price RN White NJ, Lindegardh N Tarning J, Duffull SB,, Malar J 2009 8 189 10.1186/1475-2875-8-189 19656413
4. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Barnes KI Little F, Smith PJ Evans A, Watkins WM White NJ, Clin Pharmacol Ther 2006 80 582 596 10.1016/j.clpt.2006.08.016 17178260 (Pubitemid 44920218)
5. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. McGready R Stepniewska K, Ward SA Cho T, Gilveray G Looareesuwan S, White NJ Nosten F, Eur J Clin Pharmacol 2006 62 367 371 10.1007/s00228-006-0118-y 16552504
6. Optimal design in random-effects regression models. Mentre F Mallet A Baccar D,, Biometrika 1997 84 429 442 10.1093/biomet/84.2.429
7. Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients. Waterhouse TH Redmann S, Duffull SB Eccleston JA, J Pharmacokinet Pharmacodyn 2005 32 521 546 10.1007/s10928-005-0026-2 16307208
8. Artemisinin drugs: novel antimalarial agents. Price RN, Expert Opin Investig Drugs 2000 9 1815 1827 10.1517/13543784.9.8.1815 11060779 (Pubitemid 30639331)
9. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Retout S Duffull S Mentre F,, Comput Meth Prog Biomed 2001 65 141 151 10.1016/S0169-2607(00)00117-6 (Pubitemid 32220157)
10. PAGE 16 (2007) Abstr 1179. Mentre F Duffull S Gueorguieva I Hooker A, Leonov S Ogungbenro K, Retout S,, http://www.page-meeting.org/?abstract=1179
11. Artemisinin Resistance in Plasmodium falciparum Malaria. Dondorp AM Nosten F Yi P Das D, Phyo AP Tarning J, Lwin KM Ariey F, Hanpithakpong W Lee SJ, Ringwald P Silamut K, Imwong M Chotivanich K, Lim P Herdman T, An S Yeung S, Singhasivanon P Day NPJ, Lindegardh N Socheat D, White NJ,, N Engl J Med 2009 361 455 67 10.1056/NEJMoa0808859 19641202
12. A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. Hanpithakpong W Kamanikom B Dondorp AM Singhasivanon P, White NJ Day NP, Lindegardh N,, J Chromatogr B Analyt Technol Biomed Life Sci 2008 876 61 68 10.1016/j.jchromb.2008.10.018 18990614
13. Beal SL Sheiner LB Boeckmann AJ,, NONMEM Users Guides Icon Development Solutions, Ellicott City, Maryland, USA 1989 2006
14. Wings for NONMEM. Holford NHG, http://wfn.sourceforge.net/
15. WWARN - World Wide Antimalarial Resistance Network. http://www.wwarn.org
16. POPT - Installation and user guide. Ver 3.0. Duffull SB, 2006 http://www.winpopt.com
17. Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. Roos JF Kirkpatrick CMJ Tett SE McLachlan AJ, Duffull SB,, Br J Clin Pharmacol 2008 66 455 466 10.1111/j.1365-2125.2008.03247.x 18699833
18. Methods of robust design of nonlinear models with an application to pharmacokinetics. Foo LK Duffull SB, J Biopharm Stat 2010 20 886 902 10.1080/10543401003618918 20496212
19. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. Simpson JA Agbenyega T Barnes KI Perri GD, Folb P Gomes M, Krishna S Krudsood S, Looareesuwan S Mansor S, McIlleron H Miller R, Molyneux M Mwenechanya J, Navaratnam V Nosten F, Olliaro P Pang L, Ribeiro I Tembo M, van Vugt M Ward S, Weerasuriya K Win K, White NJ,, PLoS Med 2006 3 2113 2123 (Pubitemid 44875944)
20. Population pharmacokinetics of artesunate and amodiaquine in African children. Stepniewska K Taylor W, Sirima SB Ouedraogo EB, Ouedraogo A Gansané A, Simpson JA Morgan CC, White NJ Kiechel JR, Malar J 2009 8 200 10.1186/1475-2875-8-200 19691851
21. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria. Morris CA Onyamboko MA Capparelli E Koch MA, Atibu J Lokomba V, Douoguih M Hemingway-Foday J, Wesche D Ryder RW, Bose C Wright L, Tshefu AK Meshnick S, Fleckenstein L,, Malar J 2011 10 114 10.1186/1475-2875-10-114 21548983
22. Pharmacokinetics of two paediatric artesunate-meoquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. Ramharter M Kurth FM Belard S Bouyou-Akotet MK, Mamfoumbi MM Agnandji ST, Missinou MA Adegnika AA, Issifou S Cambon N, Heidecker JL Kombila M, Kremsner PG,, J Antimicrob Chemother 2007 60 1091 1096 10.1093/jac/dkm355 17884832 (Pubitemid 47617759)
23. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. Miller AK Bandyopadhyay N Wootton DG Duparc S, Kirby PL Winstanley PA, Ward SA,, Eur J Clin Pharmacol 2009 65 977 987 10.1007/s00228-009-0672-1 19517101
24. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. Onyamboko MA Meshnick SR, Fleckenstein L Koch MA, Atibu J Lokomba V, Douoguih M Hemingway-Foday J, Wesche D Ryder RW, Bose C Wright LL, Tshefu AK Capparelli EV, Malar J 2011 10 49 10.1186/1475-2875-10-49 21352601
25. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ Pongtavornpinyo W, Maude RJ Saralamba S, Aguas R Stepniewska K, Lee SJ Dondorp AM, White LJ Day NPJ, Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
26. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Barnes KI Lindegardh N, Ogundahunsi O Olliaro P, Plowe CV Randrianarivelojosia M, Gbotosho GO Watkins WM, Sibley CH White NJ, Malar J 2007 6 122 10.1186/1475-2875-6-122 17822537
27. A Research Agenda to Underpin Malaria Eradication. Alonso PL Brown G Arevalo-Herrera M Binka F, Chitnis C Collins F, Doumbo O Greenwood B, Hall BF Levine MM, Mendis K Newman RD, Plowe CV Rodríguez MH, Sinden R Slutsker L, Tanner M,, PLoS Med 2011 8 1
28. Maturation and growth of renal function: Dosing renally cleared drugs in children. Hayton WL, AAPS PharmSci 2002 2 rticle 3
29. Glucuronidation of Dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-Glucuronosyltransferases. Ilett KF Ethell BT, Maggs JL Davis TME, Batty KT Burchell B, Binh TQ Thu LTA, Hung NC Pirmohamed M, Park BK Edwards G, Drug Metabolism and Disposition 2002 30 1006 1012
30. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Bouwmeester NJ Anderson BJ, Tibboel D Holford NH, Br J Anaesth 2004 92 208 217 10.1093/bja/aeh042 14722170 (Pubitemid 38159658)
31. Dost F, Grundlagen der Pharmakokinetik G. Thieme, Stuttgart: 2. Gufl 1968 38 47